SCHEMBL4793364

SCHEMBL4793364

COc1cc2c(SCCc3ccccc3)c(C(=O)Nc3nnn[nH]3)sc2cc1C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.39
PIK3CD O00329 1/20 0.38
NPC1 O15118 2/20 0.37
ABL1 P00519 1/20 0.37
SRC P12931 1/20 0.37
LMNA P02545 2/20 0.35
ALDH1A1 P00352 3/20 0.35
MAPT P10636 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
HTT P42858 1/20 0.35
TAAR1 Q96RJ0 1/20 0.35
TAS1R3 Q7RTX0 1/20 0.34
TAS1R1 Q7RTX1 1/20 0.34
NOX1 Q9Y5S8 2/20 0.34
HSD17B10 Q99714 3/20 0.34
KDM4E B2RXH2 2/20 0.34
HPGD P15428 2/20 0.34
RXFP1 Q9HBX9 2/20 0.34
USP2 O75604 1/20 0.34
RAB9A P51151 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6808614 0.94 POLB (0.40) POLBNPC1ABL1SRCLMNA
SCHEMBL6812831 0.87 POLB (0.42) POLBNPC1LMNAALDH1A1MAPT
SCHEMBL4763527 0.86 PIK3CD (0.40) POLBPIK3CDNPC1LMNAMAPT
SCHEMBL4762949 0.84 PIK3CD (0.38) POLBPIK3CDABL1SRCMAPT
SCHEMBL5821279 0.82 PIK3CD (0.38) POLBPIK3CDABL1SRCLMNA
SCHEMBL4792844 0.82 FFAR1 (0.41) PIK3CDNPC1ABL1SRCLMNA
SCHEMBL4762897 0.82 PIK3CD (0.39) POLBPIK3CDABL1SRCALDH1A1
SCHEMBL6811249 0.82 MAPT (0.40) POLBNPC1LMNAMAPTSMN1; SMN2
SCHEMBL4791805 0.81 EDNRA (0.45) POLBPIK3CDALDH1A1MAPTSMN1; SMN2
SCHEMBL5793171 0.81 PIK3CD (0.40) POLBPIK3CDLMNAMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080287469-A1 Phosphoinositide 3-Kinase Inhibitors for Inhibiting Leukocyte Accumulation DIACOVO THOMAS G 2008-11-20 US claimed
EP-1885356-A2 PHOSPHOINOSITIDE 3-KINASE INHIBITORS FOR INHIBITING LEUKOCYTE ACCUMULATION ICOS CORPORATION (US) 2008-02-13 EP claimed
WO-2006089106-A2 PHOSPHOINOSITIDE 3-KINASE INHIBITORS FOR INHIBITING LEUKOCYTE ACCUMULATION ICOS CORPORATION (US) 2006-08-24 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080287469-A1 Phosphoinositide 3-Kinase Inhibitors for Inhibiting Leukocyte Accumulation PI4KB, PIK3CA, PI4KA POLB 1351/4885PIK3CD 4/4885NPC1 3415/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.